Latest News and Press Releases
Want to stay updated on the latest news?
-
Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Sanuwave Announces Q3 FY2025 Financial Results
-
Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results
-
CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)
-
Sanuwave Health to Present at Canaccord Genuity Growth Conference
-
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history. Q1 2024...
-
SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023
SANUWAVE is Pleased to Announce Preliminary Revenues of $4.7 Million to $4.9 Million for the Third Quarter Ended September 30, 2023 Results Indicate 13-18% Growth Rate Over Q3 2022 UltraMist...
-
SUWANEE, GA, July 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a Medical Device Company Specializing in Chronic Wound Care, Helps Treat Football Legend Jim...
-
SANUWAVE announces patents issued over the past year SUWANEE, GA, April 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (SNWV) focuses on the development and...
-
Sales Funnel and System Trials Increase 13% Month Over MonthLaunches Entry into Two New Vertical Markets; Initial Orders Exceed $1 million SUWANEE, GA, April 08, 2022 (GLOBE NEWSWIRE) -- via...